Enliven Therapeutics shares owned by ProShare Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by ProShare Advisors
from 13F filings
Historical chart of ProShare Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by ProShare Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $328k | 8.4k | 39.20 |
| 2025-03-31 | $199k | 10k | 19.68 |
| 2024-12-31 | $275k | 12k | 22.50 |
| 2024-09-30 | $241k | 9.4k | 25.54 |